Modification of the pulmonary renin–angiotensin system and lung structural remodelling in congestive heart failure
Authors:
Open Access
- 15 August 2006
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 111 (3) , 217-224
Abstract
Lung structural remodelling, characterized by myofibroblast proliferation and collagen deposition, contributes to impaired functional capacity in CHF (congestive heart failure). As the lung is the primary site for the formation of Ang II (angiotensin II), local modifications of this system could contribute to lung remodelling. Rats with CHF, induced following myocardial infarction (MI) via coronary artery ligation, were compared with sham-operated controls. The MI group developed lung remodelling as confirmed by morphometric measurements and immunohistochemistry. Pulmonary Ang II concentrations increased more than 6-fold (PP3H]thymidine incorporation. In normal rats, chronic intravenous infusion of Ang II (0.5 mg·kg−1 of body weight·day−1) for 28 days significantly increased mean arterial pressure (P<0.05), without pulmonary hypertension, lung remodelling or a change in AT1 receptor expression. We conclude that there is a modification of the pulmonary renin–angiotensin system in CHF, with increased Ang II levels and AT1 receptor expression on myofibroblasts. Although this may contribute to lung remodelling, the lack of effect of increased plasma Ang II levels alone suggests the importance of local pulmonary Ang II levels combined with the effect of other factors activated in CHF.Keywords
This publication has 22 references indexed in Scilit:
- Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonistThorax, 2004
- AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post‐MIBritish Journal of Pharmacology, 2003
- The Angiotensin II AT2 Receptor Is an AT1Receptor AntagonistJournal of Biological Chemistry, 2001
- Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failureJACC, 2000
- LU135252, an endothelinA receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarctionBritish Journal of Pharmacology, 2000
- Role of N-Glycosylation in the Expression and Functional Properties of Human AT1ReceptorBiochemistry, 1999
- Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membraneClinical Science, 1999
- Cultured Myofibroblasts Generate Angiotensin Peptidesde NovoJournal of Molecular and Cellular Cardiology, 1997
- Angiotensin and bradykinin peptides in rats with myocardial infarctionJournal of Cardiac Failure, 1997
- Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.Circulation Research, 1994